STOCK TITAN

Avinger to Announce Second Quarter 2021 Results on August 10, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Avinger, Inc. (Nasdaq:AVGR), a medical device company, will release its Q2 2021 financial results on August 10, 2021, after market close. The company offers the first intravascular image-guided system for treating Peripheral Artery Disease (PAD), impacting over 12 million people in the U.S. A conference call will be held at 1:30 PM PT / 4:30 PM ET, which can be accessed via phone or webcast. A replay will also be available on Avinger's website.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, CA / ACCESSWIRE / July 27, 2021 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it will release its financial results for the second quarter 2021 after the close of trading on Tuesday, August 10, 2021. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.

To join the call by telephone, please dial +1-862-298-0840. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at http://www.avinger.com.

A replay of the webcast will be made available on Avinger's website, www.avinger.com, shortly after completion of the call.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot and TigereyeTM family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Follow Avinger on Twitter and Facebook.

Investor Contact:

Mark Weinswig
Chief Financial Officer
Avinger, Inc.
(650) 241-7916
ir@avinger.com

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.



View source version on accesswire.com:
https://www.accesswire.com/657210/Avinger-to-Announce-Second-Quarter-2021-Results-on-August-10-2021

FAQ

When will Avinger announce its Q2 2021 financial results?

Avinger will announce its Q2 2021 financial results on August 10, 2021, after market close.

What time is Avinger's conference call for Q2 2021 results?

The conference call for Avinger's Q2 2021 results will begin at 1:30 PM PT / 4:30 PM ET.

How can I access the webcast of Avinger's Q2 2021 conference call?

You can access the live webcast of the conference call on Avinger's investor relations page on their corporate website.

What is the significance of Avinger's Lumivascular platform?

Avinger's Lumivascular platform is the first and only image-guided system for diagnosing and treating Peripheral Artery Disease.

Avinger, Inc.

NASDAQ:AVGR

AVGR Rankings

AVGR Latest News

AVGR Stock Data

1.52M
2.93M
13.6%
2.84%
5.61%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
REDWOOD CITY